Polymyxin B For Inj.

What is Polymyxin B For Injection?

Polymyxin B For Injection is an antibiotic used under specialist medical supervision to treat selected serious infections caused by susceptible bacteria, particularly certain Gram-negative organisms. It may be considered when other treatment options are unsuitable or ineffective. Its use requires careful attention to kidney function, neurological effects and the approved product information.

Uses / Indications

Polymyxin B may be used for selected serious infections caused by susceptible bacteria, depending on local approvals and clinical guidance, including:

• Certain serious infections caused by susceptible Gram-negative bacteria.

• Selected infections involving multidrug-resistant organisms.

• Infections where alternative antibiotics are unsuitable based on susceptibility results and clinical assessment.

Polymyxin B is not effective against viral infections. Treatment should be guided by microbiology results and specialist advice whenever possible.

Benefits

• Provides antibacterial activity against selected susceptible Gram-negative bacteria.

• May be an option for certain serious infections involving multidrug-resistant organisms.

• Offers a listed strength of 5,00,000 IU for pharmaceutical sourcing requirements.

• Can be used in specialist-supervised treatment when clinically appropriate.

Side Effects

Common side effects

• Tingling or unusual sensations.

• Dizziness.

• Muscle weakness.

• Injection-related reactions, depending on the route of administration.

Less common or serious side effects

• Kidney injury or worsening renal function.

• Significant neurological effects, including severe muscle weakness.

• Respiratory muscle weakness or breathing difficulties.

• Severe allergic reactions.

• Other adverse effects associated with the approved formulation and administration route.

Seek urgent medical attention for breathing difficulty, marked muscle weakness, reduced urine output or signs of a severe allergic reaction.

How Does It Work?

Polymyxin B binds to components of the bacterial cell membrane, particularly lipopolysaccharides in susceptible Gram-negative bacteria. This disrupts membrane integrity, causing leakage of cellular contents and bacterial death. Its activity is limited to susceptible organisms, and its potential toxicity means that careful clinical monitoring is important.

Dosage Guidelines

The prescribed regimen depends on the infection, its severity, the patient’s body weight, kidney function, clinical response and the approved product information.

• Use only under qualified medical supervision.

• The prescribed dose must be calculated using the correct units and applicable dosing guidance.

• Administration route, preparation and dilution must follow the approved product instructions.

• Monitor kidney function and neurological status as clinically indicated.

• Do not infer preparation volumes or administration instructions from the stated vial strength alone.

The exact dose, administration route, frequency and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Polymyxin B should not be used in patients with a known serious hypersensitivity to polymyxin B or any formulation component, unless the applicable approved product information and specialist assessment establish otherwise.

Extra caution is necessary in patients with impaired kidney function, pre-existing neurological disorders or conditions that may increase the risk of neuromuscular weakness.

Drug / Product Interactions

Potentially important interactions include:

• Aminoglycoside antibiotics: May increase the risk of kidney injury or neurological toxicity.

• Neuromuscular-blocking medicines: May increase or prolong neuromuscular blockade and respiratory weakness.

• Other nephrotoxic medicines: May increase the risk of kidney injury.

• Medicines associated with neurotoxicity: May increase the need for monitoring.

All current medicines should be reviewed by a qualified healthcare professional before treatment.

Safety Advice

• Use only when clinically indicated for a susceptible bacterial infection.

• Assess kidney function before and during treatment as appropriate.

• Monitor for neurological symptoms, muscle weakness and breathing difficulties.

• Avoid unnecessary concurrent use of medicines that may increase kidney or neurological toxicity.

• Follow antimicrobial stewardship guidance to help limit the development of resistance.

General Instructions

• Verify the product name, strength, vial integrity and expiry date before use.

• Confirm whether WFI is included and check the approved preparation instructions.

• Prepare and administer using appropriate aseptic procedures.

• Do not use damaged or compromised packaging.

• Do not mix with other medicines unless compatibility has been confirmed in the approved product information.

Special Dietary / Lifestyle Tips

No specific universal diet is required for Polymyxin B. Patients should follow their healthcare professional’s advice on hydration and any restrictions related to kidney function or other medical conditions. Report reduced urine output, unusual weakness, tingling or breathing difficulties promptly.

Comparison with Other Treatments

Polymyxin B belongs to the polymyxin class and differs from beta-lactam antibiotics, including penicillins and carbapenems. It may be considered for selected difficult-to-treat Gram-negative infections, but its toxicity profile and the susceptibility of the organism are important considerations. The choice of antibiotic should be based on culture and susceptibility results, infection severity, patient factors and current clinical guidance.

Precautions & Warnings

• Kidney toxicity: Renal function requires appropriate monitoring.

• Neurological toxicity: Watch for tingling, weakness or other neurological symptoms.

• Respiratory risk: Neuromuscular effects may affect breathing.

• Drug interactions: Concomitant nephrotoxic or neuromuscular-blocking medicines require careful review.

• Pregnancy and breastfeeding: Use requires an individual clinical risk-benefit assessment.

• Paediatric use: Dosing and suitability require specialist assessment and approved product guidance.

• Antimicrobial resistance: Use should be guided by clinical need and microbiology results.

Can I Use It With Other Medicines?

Generally Compatible With

Other medicines may be used when clinically necessary, following an interaction review and appropriate monitoring by the treating healthcare professional.

Use With Caution

• Aminoglycoside antibiotics.

• Medicines that may affect kidney function.

• Neuromuscular-blocking medicines.

• Other medicines associated with neurological or respiratory muscle effects.

Avoid

• Avoid unnecessary concurrent use of other nephrotoxic or neurotoxic medicines where safer alternatives are available.

• Do not mix Polymyxin B with another medicine in the same container or infusion line unless compatibility is confirmed by the approved product information.

Storage

Store according to the specific product label and approved product information. Requirements may differ between unopened vials and prepared solutions. Confirm the appropriate temperature, light protection and permitted in-use period from the approved instructions.

Frequently Asked Questions

1. What is Polymyxin B For Injection used for?

It is used under specialist medical supervision to treat selected serious infections caused by susceptible bacteria, particularly certain Gram-negative organisms.

2. What is the strength of this product?

The supplied product details list Polymyxin B For Injection at 5,00,000 IU.

3. Is Polymyxin B a carbapenem antibiotic?

No. Polymyxin B belongs to the polymyxin class of antibiotics, not the beta-lactam or carbapenem classes.

4. Does the vial include Water for Injection?

The supplied description states “With WFI”. Confirm whether WFI is included with the product and follow the approved preparation instructions.

5. What are the main safety concerns with Polymyxin B?

Important concerns include kidney injury, neurological toxicity and possible respiratory muscle weakness. Appropriate monitoring is essential.

6. Can Polymyxin B be used for viral infections?

No. It is an antibacterial medicine and does not treat viral infections such as influenza or the common cold.

7. Does Polymyxin B require kidney-function monitoring?

Yes. Kidney function should be assessed and monitored as appropriate during treatment because renal toxicity is an important safety concern.

8. How can international buyers enquire about this product?

International buyers can contact Kelar Pharmachem India to enquire about sourcing, vial presentation and available product documentation, subject to confirmation and availability.Polymyxin B Injection